ADC Therapeutics SA approved one-time retention awards for CEO Ameet Mallik, CFO Jose Carmona, and CMO Mohamed Zaki. The awards consist of cash incentives and Restricted Stock Units (RSUs) totaling $1,795,500 in cash and 675,000 RSUs for the CEO, with other specific amounts for the CFO and CMO. ADC Therapeutics SA is a biotechnology company focused on developing oncology treatments.
